Daniel Laheru, MD

Daniel Laheru, MD

Co-Director, Skip Viragh Center for Pancreas Center; Associate Professor of Oncology

Johns Hopkins School of Medicine

Dr. Daniel Laheru is a pancreatic cancer specialist at Johns Hopkins Medical Center in Baltimore, Maryland. He is co-director of the Skip Viragh Center for Pancreas Cancer. He received his medical degree at Baylor Colloge of Medicine and his residency at the University of Utah. In collaboration with Dr. Elizabeth Jaffee, Laheru has developed clinical studies to optimize an immune therapy approach using GM-CSF transfected pancreatic cell lines as a vaccine in two distinct patient populations. First, the vaccine has been integrated with chemotherapy and radiation therapy in patients with resected pancreatic cancer who are at risk for disease recurrence. Second, the vaccine has been integrated with novel molecular targeted drugs such as EGFR inhibitors and anti-CTLA-4 antibody and with immune modulating doses of Cytoxan in patients with metastatic pancreatic cancer. He has also incorporated correlative studies that should provide important information to better understand optimal vaccine boosting schedules as well as to identify antigens that can be predictive markers for anti-pancreatic cancer immune responses.

Programs featuring Daniel Laheru, MD

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on August 20, 2014